Clinical trial
Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed…
NCT00313521 · Children's Cancer and Leukaemia Group, Other · Unknown status
Key facts
| NCT number | NCT00313521 |
|---|---|
| Title | Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors |
| Official title | Continuous Infusion Thiotepa in High Grade Astrocytic Tumors of Childhood and Adolescence A UKCCSG Phase II Study Involving the Brain Tumour and New Agent Groups |
| Lead sponsor | Children's Cancer and Leukaemia Group, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | thiotepa, adjuvant therapy, radiation therapy |
| Enrollment | 30 |
| Start date | Jun 1, 1995 |
| Primary completion | Nov 1, 1997 |
| First posted | Apr 12, 2006 |
| Last update posted | Sep 20, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: